Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury

Ulrich Tigges, Masanobu Komatsu, William B. Stallcup

Research output: Contribution to journalArticle

Abstract

Restenosis is a major complication of coronary angioplasty, at least partly due to the fact that the origin and identity of contributing cell types are not well understood. In this study, we have investigated whether pericyte-like cells or mesenchymal stem cells (MSCs) from the adventitia contribute to restenosis. We demonstrate that while cells expressing the pericyte markers NG2, platelet-derived growth factor receptor β, and CD146 are rare in the adventitia of uninjured mouse femoral arteries, following injury their numbers strongly increase. Some of these adventitial pericyte-like cells acquire a more MSC-like phenotype (CD90+ and CD29+ are up-regulated) and also appear in the restenotic neointima. Via bone marrow transplantation and ex vivo artery culture approaches, we demonstrate that the pericyte-like MSCs of the injured femoral artery are not derived from the bone marrow, but originate in the adventitia itself mainly via the proliferation of resident pericyte-like cells. In summary, we have identified a population of resident adventitial pericyte-like cells or MSCs that contribute to restenosis following arterial injury. These cells are different from myofibroblasts, smooth muscle cells, and other progenitor populations that have been shown to participate in the restenotic process.

Original languageEnglish (US)
Pages (from-to)134-144
Number of pages11
JournalJournal of Vascular Research
Volume50
Issue number2
DOIs
StatePublished - Feb 1 2013
Externally publishedYes

Fingerprint

Adventitia
Pericytes
Mesenchymal Stromal Cells
Wounds and Injuries
Femoral Artery
Platelet-Derived Growth Factor Receptors
Neointima
Myofibroblasts
Bone Marrow Transplantation
Angioplasty
Population
Smooth Muscle Myocytes
Arteries
Bone Marrow
Phenotype

Keywords

  • Adventitia
  • Coronary angioplasty
  • Mesenchymal stem cells
  • Pericyte-like cells
  • Pericytes
  • Restenosis

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury. / Tigges, Ulrich; Komatsu, Masanobu; Stallcup, William B.

In: Journal of Vascular Research, Vol. 50, No. 2, 01.02.2013, p. 134-144.

Research output: Contribution to journalArticle

@article{0bc0985a67954493a0358bdc45df6c8c,
title = "Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury",
abstract = "Restenosis is a major complication of coronary angioplasty, at least partly due to the fact that the origin and identity of contributing cell types are not well understood. In this study, we have investigated whether pericyte-like cells or mesenchymal stem cells (MSCs) from the adventitia contribute to restenosis. We demonstrate that while cells expressing the pericyte markers NG2, platelet-derived growth factor receptor β, and CD146 are rare in the adventitia of uninjured mouse femoral arteries, following injury their numbers strongly increase. Some of these adventitial pericyte-like cells acquire a more MSC-like phenotype (CD90+ and CD29+ are up-regulated) and also appear in the restenotic neointima. Via bone marrow transplantation and ex vivo artery culture approaches, we demonstrate that the pericyte-like MSCs of the injured femoral artery are not derived from the bone marrow, but originate in the adventitia itself mainly via the proliferation of resident pericyte-like cells. In summary, we have identified a population of resident adventitial pericyte-like cells or MSCs that contribute to restenosis following arterial injury. These cells are different from myofibroblasts, smooth muscle cells, and other progenitor populations that have been shown to participate in the restenotic process.",
keywords = "Adventitia, Coronary angioplasty, Mesenchymal stem cells, Pericyte-like cells, Pericytes, Restenosis",
author = "Ulrich Tigges and Masanobu Komatsu and Stallcup, {William B.}",
year = "2013",
month = "2",
day = "1",
doi = "10.1159/000345524",
language = "English (US)",
volume = "50",
pages = "134--144",
journal = "Journal of Vascular Research",
issn = "1018-1172",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury

AU - Tigges, Ulrich

AU - Komatsu, Masanobu

AU - Stallcup, William B.

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Restenosis is a major complication of coronary angioplasty, at least partly due to the fact that the origin and identity of contributing cell types are not well understood. In this study, we have investigated whether pericyte-like cells or mesenchymal stem cells (MSCs) from the adventitia contribute to restenosis. We demonstrate that while cells expressing the pericyte markers NG2, platelet-derived growth factor receptor β, and CD146 are rare in the adventitia of uninjured mouse femoral arteries, following injury their numbers strongly increase. Some of these adventitial pericyte-like cells acquire a more MSC-like phenotype (CD90+ and CD29+ are up-regulated) and also appear in the restenotic neointima. Via bone marrow transplantation and ex vivo artery culture approaches, we demonstrate that the pericyte-like MSCs of the injured femoral artery are not derived from the bone marrow, but originate in the adventitia itself mainly via the proliferation of resident pericyte-like cells. In summary, we have identified a population of resident adventitial pericyte-like cells or MSCs that contribute to restenosis following arterial injury. These cells are different from myofibroblasts, smooth muscle cells, and other progenitor populations that have been shown to participate in the restenotic process.

AB - Restenosis is a major complication of coronary angioplasty, at least partly due to the fact that the origin and identity of contributing cell types are not well understood. In this study, we have investigated whether pericyte-like cells or mesenchymal stem cells (MSCs) from the adventitia contribute to restenosis. We demonstrate that while cells expressing the pericyte markers NG2, platelet-derived growth factor receptor β, and CD146 are rare in the adventitia of uninjured mouse femoral arteries, following injury their numbers strongly increase. Some of these adventitial pericyte-like cells acquire a more MSC-like phenotype (CD90+ and CD29+ are up-regulated) and also appear in the restenotic neointima. Via bone marrow transplantation and ex vivo artery culture approaches, we demonstrate that the pericyte-like MSCs of the injured femoral artery are not derived from the bone marrow, but originate in the adventitia itself mainly via the proliferation of resident pericyte-like cells. In summary, we have identified a population of resident adventitial pericyte-like cells or MSCs that contribute to restenosis following arterial injury. These cells are different from myofibroblasts, smooth muscle cells, and other progenitor populations that have been shown to participate in the restenotic process.

KW - Adventitia

KW - Coronary angioplasty

KW - Mesenchymal stem cells

KW - Pericyte-like cells

KW - Pericytes

KW - Restenosis

UR - http://www.scopus.com/inward/record.url?scp=84871235918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871235918&partnerID=8YFLogxK

U2 - 10.1159/000345524

DO - 10.1159/000345524

M3 - Article

VL - 50

SP - 134

EP - 144

JO - Journal of Vascular Research

JF - Journal of Vascular Research

SN - 1018-1172

IS - 2

ER -